Feb 21 (Reuters) - Healius Ltd (HLS) :
- NOW EXPECTS UNDERLYING FY 2024 EBITDA OF A$359 MILLION - A$369 MILLION
- VOLUME GROWTH SEEN IN Q1 OF FY 2024 HAS SOFTENED
- EXPECTS UNDERLYING EBITDA OF A$158 MILLION - A$161 MILLION FOR HY
- NON-CASH IMPAIRMENT CHARGE OF A$603 MILLION WILL BE MADE TO GOODWILL IN PATHOLOGY DIVISION IN 1H 2024 RESULTS
- RESPONDING TO SOFTENED VOLUME GROWTH WITH ACCELERATED PLAN TO RESHAPE BUSINESS AND MATCH COSTS TO CURRENT VOLUMES
News: HLS Healius Expects Underlying FY 2024 EBITDA Of A$359 Million - A$369 Million
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
83.0¢ |
Change
0.005(0.61%) |
Mkt cap ! $600.8M | |||
| Open | High | Low | Value | Volume |
| 81.5¢ | 84.5¢ | 81.5¢ | $2.319M | 2.783M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15737 | 89.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 81.0¢ | 8420 | 1 |
View Market Depth
| Last trade - 15.59pm 08/09/2025 (20 minute delay) ? |
| HLS (ASX) Chart |